ERalpha and ERbeta expression and transcriptional activity are differentially regulated by HDAC inhibitors

The proliferative action of ERα largely accounts for the carcinogenic activity of estrogens. By contrast, recent data show that ERβ displays tumor-suppressor properties, thus supporting the interest to identify compounds which could increase its activity. Here, we show that histone deacetylase inhib...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Duong, Vanessa, Licznar, Anne, Margueron, Raphaël, Boulle, Nathalie, Busson, Muriel, Lacroix, Matthieu, Katzenellenbogen, Benita S., Cavaillès, Vincent, Lazennec, Gwendal
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2006
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2034758/
https://ncbi.nlm.nih.gov/pubmed/16158045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.onc.1209102
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares